Company & Sponsor Intelligence

University of Glasgow

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed1

Countries1

Therapeutic footprint

anxietydepressionsubstance_use

Indexed studies

NCT00980824ENGAGE - Meeting Mental Health Needs of Complex Comorbid Patients
substance_use · United KingdomPHASE1, PHASE2

NCT04746651A Feasibility Study of a Guided Self-help Programme for Male Offenders Serving a Long-term Prison Sentence
depression · United KingdomNA

NCT00355693Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol in Anxious Patients
anxiety · United KingdomPHASE4

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →